Call for new members to join existing 24 ERNs

The first call for new members to join existing 24 ERNs has been launched TODAY, 30 of September 2019 until 30 of November 2019. HOW TO APPLY TO BECOME A MEMBER OF AN ERN?The membership application process will involve several steps: Review the information that is included on the Commission webpage related to the European Reference Networks and…

EJP RD at the European Research and Innovation Days

The EJP RD Coordinator, Dr. Daria Julkowska, participated to this first annual policy event of the European Commission, bringing together stakeholders to debate and shape the future research and innovation landscape. Dr. Julkowska was part of the « Tackling Rare diseases » session together with Anne Paoletti (French Research Ministry, France), Andrzej Rys (European Commission, DG SANTE,…

New IRDIRC Recognized Resource: « The Model Organism Aggregated Resources for Rare Variant ExpLoration (MARRVEL) »

MARRVEL (Model organism Aggregated Resources for Rare Variant ExpLoration), a new IRDiRC recognized resource, is available online! It is a search engine that collects data from a number of human genomics and model organism genetics databases and displays it in a rapid user-friendly format. <<MARRVEL is a publicly available website that integrates information from six…

Global public meeting on draft ICH guideline on clinical trials

The global guidance for the conduct of clinical trials is currently undergoing a major revision. As part of the worldwide consultation process, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is organising a public meeting to review its draft E8 (R1) Guideline ‘General Considerations for Clinical Trials’. EMA is encouraging its stakeholders to register…

New Elixir paper published in Nature: « Leveraging European infrastructures to access 1 million human genomes by 2022 »

ELIXIR team has recently published in Nature Reviews Genetics. The article explores how European research infrastructures can be leveraged to facilitate transnational access to at least one million human genomes. This is building on the recently declared ‘European ‘1+ Million Genomes’ initiative’ signed by 21 European countries, which is targeted for completion by 2022. In…